# US Bioresorbable Polymers Market > US Bioresorbable Polymers Market Research Report: By Type (Agro-Polymers, Bio-Polyesters) and By Application (Orthopedic, Drug Delivery, Biodegradable Devices, Others) - Forecast to 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 12.8% - **2024:** $ 267.04 Million - **2025:** $ 301.22 Million - **2035:** $ 1,004.56 Million - **Key Players:** BASF SE (DE), Corbion NV (NL), Evonik Industries AG (DE), Medtronic PLC (IE), Boehringer Ingelheim GmbH (DE), Poly-Med Inc (US), Fujifilm Corporation (JP), Sientra Inc (US), Galatea Surgical Inc (US) **Report ID:** MRFR/CnM/11953-HCR · **Pages:** 100 · **Author:** Chitranshi Jaiswal · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/us-bioresorbable-polymers-market-13478 --- ## Market Summary ## **US Bioresorbable Polymers Market Overview** The US Bioresorbable Polymers Market Size was estimated at 237 (USD Million) in 2023. The US Bioresorbable Polymers Industry is expected to grow from 238.5(USD Million) in 2024 to 1,006.5 (USD Million) by 2035. The US Bioresorbable Polymers Market CAGR (growth rate) is expected to be around 13.985% during the forecast period (2025 - 2035). ### **Key US Bioresorbable Polymers Market Trends Highlighted** In the US Bioresorbable Polymers Market, key market drivers include an increasing demand in the medical sector, particularly due to the rise in minimally invasive surgeries and orthopedic procedures. Organizations such as the U.S. Food and Drug Administration (FDA) support the development of bioresorbable materials for medical devices, which drives innovation in this sector. Additionally, advancements in technology related to polymer synthesis and processing enhance the functionality and applicability of these materials, making them more appealing to healthcare providers. There are significant opportunities to be explored, particularly in the areas of drug delivery systems and tissue engineering.The growing trend of personalized medicine creates a niche market for bioresorbable polymers that can be tailored for specific patients or treatment protocols. Collaborations between biotechnology firms and research institutions are also paving the way for novel applications, leading to increased investment in bioresorbable polymers. Recent trends show a heightened awareness and demand for sustainable products, urging manufacturers in the US to focus on eco-friendly bioresorbable options. This shift reflects a broader commitment to environmental sustainability within the healthcare sector. Increased regulatory support is also evident; this encourages the use of bioresorbable polymers across various applications, from sutures to implants.Innovations in material characteristics and the push towards eco-conscious solutions are significant forces shaping the direction of the US Bioresorbable Polymers Market in the near future. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **US Bioresorbable Polymers Market Drivers** Increasing Demand for Minimally Invasive Surgical Procedures The shift toward minimally invasive surgical procedures in the United States is a significant driver for the US Bioresorbable Polymers Market Industry. Innovative surgical practices are increasingly favored due to their associated benefits such as reduced recovery time, lower risk of infection, and decreased scarring. According to the American Society for Gastrointestinal Endoscopy, procedures performed with minimally invasive techniques grew by over 30% in the past decade, with an increasing number projected in various surgical specialties.As hospitals and clinics transition to these advanced techniques, the demand for bioresorbable polymers is anticipated to rise, predominantly because they support surgical operations with materials that eliminate the need for additional surgery to remove implants. Major medical device companies such as Medtronic and Boston Scientific are investing heavily in bioresorbable technologies to cater to this growing market and address evolving surgical needs. Rising Prevalence of Chronic Diseases The prevalence of chronic diseases such as cardiovascular disorders, diabetes, and orthopedic conditions is rising in the United States, driving demand for bioresorbable polymers. The Centers for Disease Control and Prevention (CDC) report that approximately 6 in 10 adults in the US have a chronic disease, and this is projected to increase as the population ages. Bioresorbable polymers play an essential role in providing scaffolding for tissue engineering and organ regeneration, which is critical in treating these diseases effectively.Medical organizations, including the American Heart Association, are actively researching bioresorbable materials for applications in stents and surgical implants, highlighting the growing intersection between healthcare needs and innovative materials. The consistent push from healthcare professionals toward finding efficient and effective solutions signifies a robust market potential for bioresorbable polymers in the realm of chronic disease management. Technological Advancements in Medical Devices Continuous advancements in medical device technology are a key driver for the US Bioresorbable Polymers Market Industry. The National Institutes of Health (NIH) have facilitated numerous grants and funding opportunities for Research and Development (R&D) focusing on biomaterials, which significantly boosts innovations in the use of bioresorbable polymers. The implementation of advanced 3D printing technology and bioengineering techniques are leading to novel applications in the medical field, as highlighted in the NIH's annual funding reports, which show an almost 20% increase in funding dedicated to this specific area over the last five years.Organizations like the Food and Drug Administration (FDA) are also encouraging the integration of bioresorbable materials in device approvals, noting that they can improve patient outcomes by reducing long-term complications associated with permanent implants. This synergy between innovation and regulatory support significantly enhances the market outlook for bioresorbable polymers in medical devices. ## **US Bioresorbable Polymers Market Segment Insights** ### **Bioresorbable Polymers Market Type Insights** The US Bioresorbable Polymers Market is witnessing robust growth driven by increasing applications in healthcare, particularly in drug delivery systems, sutures, and tissue engineering. The Type segment comprises notable categories such as Agro-Polymers and Bio-Polyesters, which are gaining recognition for their sustainable benefits and versatility. Agro-Polymers, derived from natural resources, are increasingly used in agricultural applications, including biodegradable films and seed coatings, aiding in sustainable farming practices. Their ability to reduce plastic accumulation in soil makes them significant in addressing environmental concerns.On the other hand, Bio-Polyesters are extensively utilized in medical devices and packaging, highlighting their role in converting traditional petroleum-based products to more eco-friendly solutions. Given the rising consumer awareness regarding environmental sustainability and government regulations favoring biodegradable materials, the significance of these materials in the US market is further amplified. The US Bioresorbable Polymers Market is experiencing dynamic changes and trends, with a focus on enhancing product functionality while minimizing environmental impact, thus paving the way for further innovations in these types.Consequently, both Agro-Polymers and Bio-Polyesters not only contribute to significant industrial shifts but also support the overall growth trajectory of the US Bioresorbable Polymers Market, positioning them as vital components in the future of material science and sustainability initiatives. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Bioresorbable Polymers Market Application Insights** The US Bioresorbable Polymers Market showcases a diverse application landscape, significantly impacting various sectors such as Orthopedic, Drug Delivery, Biodegradable Devices, and others. Orthopedic applications stand out with innovative solutions that enhance patient recovery by providing temporary support while minimizing complications associated with traditional implants. In Drug Delivery, the growth is driven by the ability of bioresorbable materials to provide controlled release of therapeutics, simplifying complex therapies and improving patient compliance.Biodegradable Devices, leveraging the environmental benefits of bioresorbable materials, align well with the increasing emphasis on sustainability in healthcare. Additionally, the exploration of other applications highlights the versatile nature of these polymers, catering to niche and emerging markets. Together, these factors contribute positively to the US Bioresorbable Polymers Market statistics, driven by advancements in technology and rising demand for patient-centric solutions. This segmentation emphasizes the importance of bioresorbable polymers in enhancing medical outcomes and showcasing the industry's growth potential in the coming years, backed by ongoing research and development initiatives across the US. ### **US Bioresorbable Polymers Market Key Players and Competitive Insights** The competitive landscape of the US Bioresorbable Polymers Market is characterized by a dynamic interplay of innovation, technological advancements, and strategic partnerships among various key players. Bioresorbable polymers are gaining traction primarily due to their potential applications in medical devices, drug delivery systems, and tissue engineering. Companies within this segment are increasingly focusing on developing advanced materials that are not only effective in their functionality but also meet stringent regulatory standards. The market is witnessing a surge in research and development efforts aimed at enhancing the properties of bioresorbable polymers, which cater to specific applications in the healthcare sector. This has led to an evolving competitive framework where companies are striving to leverage their technological capabilities and expertise to gain a competitive edge.BASF holds a significant position within the US Bioresorbable Polymers Market, with a strong emphasis on innovation and product development. The company leverages its extensive research capabilities and advanced polymer technology to create sophisticated solutions that cater to the demands of the healthcare industry. BASF's strengths lie in its deep knowledge of polymer chemistry and extensive manufacturing capabilities, enabling it to produce high-quality bioresorbable materials that fulfill various medical applications. The company's strategic collaborations with research institutions and healthcare companies further bolster its market presence, as these partnerships allow BASF to expand its product portfolio and enter new market segments while maintaining a focus on sustainable practices.Boehringer Ingelheim has established itself as a formidable player in the US Bioresorbable Polymers Market through its commitment to innovation and comprehensive product offerings. The company is recognized for its advanced bioresorbable polymer products that are primarily utilized in pharmaceuticals and medical devices, enabling effective drug delivery and enhanced therapeutic outcomes. Boehringer Ingelheim's strengths include its robust research and development pipeline, which is aimed at advancing drug formulation technologies and enhancing patient safety. The company’s strategic mergers and acquisitions have further fortified its market position, allowing it to integrate cutting-edge technologies and expand its capabilities within the bioresorbable sector. By focusing on quality and innovation while fostering collaborations with key stakeholders, Boehringer Ingelheim continues to strengthen its prominence within the US market. ### **Key Companies in the US Bioresorbable Polymers Market Include** ## **US Bioresorbable Polymers Market Industry Developments** The US Bioresorbable Polymers Market has seen notable developments recently. For instance, in January 2023, Medtronic announced advancements in its research initiatives focusing on bioresorbable materials aimed at enhancing patient recovery times. Various companies, including BASF and Evonik Industries, are increasing their investments in Research and Development to support the growing demand for biocompatible and sustainable materials in medical applications. Furthermore, PolyMedicure has expanded its product offerings, targeting the cardiovascular sector, capitalizing on the shift towards minimally invasive procedures.In terms of mergers and acquisitions, March 2023 marked a significant acquisition by Boehringer Ingelheim, which purchased a smaller biotech firm to strengthen its portfolio in regenerative medicine, including bioresorbable technologies. The US Bioresorbable Polymers Market is projected to grow, driven by advancements and increasing applications in medical devices, particularly in orthopedics and cardiology. Moreover, the recent emphasis on sustainability and eco-friendliness is influencing the development of bioresorbable materials across the industry. Noteworthy events in the last two to three years include the launch of innovative products by Sientra in June 2021 that further propelled the market's expansion. ## **US Bioresorbable Polymers Market Segmentation Insights** ### **Bioresorbable Polymers Market Type****Outlook** ### **Bioresorbable Polymers Market Application****Outlook** ## Market Drivers ### Rising Environmental Awareness Environmental awareness among consumers and manufacturers is driving the bioresorbable polymers market. As sustainability becomes a priority, there is a growing demand for materials that can reduce environmental impact. Bioresorbable polymers, being biodegradable, present a viable alternative to traditional plastics, particularly in packaging and medical applications. The US market for biodegradable plastics is expected to grow at a CAGR of 12% from 2021 to 2026, indicating a shift towards eco-friendly materials. This trend is likely to encourage manufacturers to invest in bioresorbable polymers, aligning their products with consumer preferences for sustainable solutions. Consequently, the bioresorbable polymers market is poised for growth as companies adapt to these changing dynamics. ### Increasing Healthcare Expenditure The rising healthcare expenditure in the US is a pivotal driver for the bioresorbable polymers market. As healthcare budgets expand, there is a growing emphasis on innovative medical solutions, including bioresorbable polymers. These materials are increasingly utilized in surgical applications, drug delivery systems, and tissue engineering. The US healthcare expenditure reached approximately $4.1 trillion in 2020, and it is projected to grow at a CAGR of around 5.4% through 2028. This trend indicates a robust demand for advanced materials that can enhance patient outcomes, thereby propelling the bioresorbable polymers market forward. Furthermore, the shift towards minimally invasive procedures aligns with the properties of bioresorbable polymers, which can reduce the need for additional surgeries, thus appealing to healthcare providers and patients alike. ### Advancements in Research and Development Advancements in research and development are significantly influencing the bioresorbable polymers market. Ongoing studies in material science are leading to the creation of new bioresorbable polymers with enhanced properties, such as improved mechanical strength and controlled degradation rates. These innovations are crucial for expanding the applications of bioresorbable materials in various fields, including drug delivery and regenerative medicine. The US government has been actively funding research initiatives aimed at developing advanced biomaterials, which further supports the growth of the bioresorbable polymers market. As new technologies emerge, they are likely to open up additional avenues for commercialization, thereby driving market expansion. ### Growing Focus on Patient-Centric Solutions The bioresorbable polymers market is experiencing growth due to an increasing focus on patient-centric solutions in the healthcare sector. As healthcare providers prioritize patient outcomes, there is a shift towards materials that minimize complications and enhance recovery. Bioresorbable polymers offer the advantage of eliminating the need for surgical removal, which aligns with the goals of improving patient experiences. The market for bioresorbable stents, for instance, is projected to reach $1.5 billion by 2026, reflecting the demand for such patient-friendly solutions. This trend indicates a broader movement within the healthcare industry towards materials that not only serve functional purposes but also contribute to overall patient satisfaction. ### Regulatory Support for Innovative Materials Regulatory bodies in the US are increasingly supportive of innovative materials, which significantly impacts the bioresorbable polymers market. The FDA has established pathways for the approval of new medical devices and materials, facilitating the entry of bioresorbable polymers into the market. This regulatory environment encourages research and development, leading to the introduction of novel applications in areas such as orthopedic implants and cardiovascular devices. The streamlined approval processes can reduce time-to-market for new products, which is crucial for companies looking to capitalize on emerging opportunities. As a result, the bioresorbable polymers market is likely to experience accelerated growth, driven by the influx of innovative solutions that meet regulatory standards. ## Future Outlook The bioresorbable polymers market is projected to grow at a 12.8% CAGR from 2025 to 2035, driven by advancements in medical applications and increasing demand for sustainable materials. **New opportunities:** - Development of biodegradable drug delivery systems for targeted therapies. - Expansion into 3D printing applications for customized medical devices. - Partnerships with healthcare providers for innovative surgical solutions. By 2035, the bioresorbable polymers market is expected to achieve substantial growth and innovation. ## Segment Insights ### By Application: Medical Devices (Largest) vs. Drug Delivery Systems (Fastest-Growing) In the US bioresorbable polymers market, the application segment is primarily dominated by medical devices, which take the largest share. This segment includes a range of products such as orthopedic implants and cardiovascular devices, which utilize bioresorbable polymers for enhanced biocompatibility and reduced foreign body response. Conversely, drug delivery systems are gaining traction with their innovative delivery mechanisms and personalized medicine adaptability. This segment is experiencing rapid growth and is attracting significant investments due to technological advancements. Currently, the demand for bioresorbable polymers in key applications like tissue engineering and surgical sutures is on the rise. The expansion of these segments can be attributed to increasing chronic diseases requiring surgical interventions and advancements in polymer technology, enabling more efficient healing and reduced risk of complications. This growth aligns with a broader trend towards minimally invasive procedures and patient-centered care, further driving the adoption of bioresorbable polymers across various applications. Medical Devices (Dominant) vs. Drug Delivery Systems (Emerging) The medical devices segment remains dominant in the US bioresorbable polymers market, characterized by its robust demand driven by advancements in surgical procedures and patient outcomes. Devices such as stents and orthopedic implants leverage the advantages of bioresorbable materials, offering reduced need for additional surgeries for device removal. In contrast, the drug delivery systems segment is emerging as a critical player, propelled by innovations that facilitate targeted and controlled release of therapeutic agents. This enables personalized medicine approaches, catering to individual patient needs. The dynamic characteristics of each segment underscore the evolving market landscape, with medical devices maintaining a stronghold while drug delivery systems rapidly carve out their space through technological breakthroughs. ### By Material Type: Polylactic Acid (Largest) vs. Polycaprolactone (Fastest-Growing) In the US bioresorbable polymers market, Polylactic Acid (PLA) dominates the material type segment due to its widespread adoption across various applications, including medical implants and sutures. Its market share is bolstered by its biodegradable properties and adaptability, leading to increased usage in industries prioritizing sustainability. Other materials like Polyglycolic Acid (PGA) and Polycaprolactone (PCL) have notable shares but lag behind PLA in total market capacity. Polylactic Acid (Dominant) vs. Polycaprolactone (Emerging) Polylactic Acid (PLA) stands out as the dominant material in the US bioresorbable polymers market owing to its extensive use in the medical field and favorable regulatory embrace. It provides excellent mechanical properties and has a proven track record in various applications. Conversely, Polycaprolactone (PCL) is emerging as a significant player, particularly in applications where flexibility and degradation time are critical. While PLA is preferred for its strength and ease of processing, PCL's unique properties allow it to meet specialized industry needs, indicating a growing trajectory in its market presence. ### By End Use: Orthopedics (Largest) vs. Wound Care (Fastest-Growing) In the US bioresorbable polymers market, Orthopedics holds the largest share, driven by its extensive application in surgical implants and fixation devices. This segment's dominance is attributed to the increasing prevalence of musculoskeletal disorders and a growing aging population requiring orthopedic surgeries. Meanwhile, Wound Care has emerged as the fastest-growing segment, fueled by advancements in bioresorbable dressings and increasing demand for effective wound healing solutions. The rising number of surgical procedures and trauma cases is further accelerating growth in this area. Orthopedics: Surgical Implants (Dominant) vs. Wound Care: Dressings (Emerging) The Orthopedics segment features surgical implants as a dominant force, leveraging bioresorbable polymers for their ability to safely and effectively support bone healing. This segment benefits from established manufacturing practices and regulatory approvals, positioning it as a crucial player in the bioresorbable landscape. In contrast, the Wound Care segment, with its emerging dressing innovations, focuses on biocompatibility and enhanced healing rates. This segment is rapidly evolving, driven by a demand for personalized medicine and advanced wound management solutions, making it a valuable area for growth and investment in the coming years. ## Competitive Benchmarking The bioresorbable polymers market is currently characterized by a dynamic competitive landscape, driven by increasing demand for sustainable medical solutions and advancements in polymer technology. Key players such as BASF SE (Germany), Medtronic PLC (Ireland), and Poly-Med Inc (US) are strategically positioned to leverage innovation and partnerships to enhance their market presence. BASF SE (Germany) focuses on developing high-performance materials that cater to the medical sector, while Medtronic PLC (Ireland) emphasizes integrating bioresorbable polymers into its medical devices, thereby enhancing patient outcomes. Poly-Med Inc (US) is dedicated to pioneering new applications for bioresorbable polymers, which collectively shapes a competitive environment that is increasingly focused on innovation and sustainability.In terms of business tactics, companies are localizing manufacturing and optimizing supply chains to enhance efficiency and responsiveness to market demands. The competitive structure of the bioresorbable polymers market appears moderately fragmented, with several players vying for market share. The collective influence of these key players is significant, as they drive technological advancements and set industry standards, thereby shaping the overall market dynamics. In October Medtronic PLC (Ireland) announced a strategic partnership with a leading research institution to develop next-generation bioresorbable stents. This collaboration is expected to enhance the efficacy of their cardiovascular devices, aligning with the growing trend towards minimally invasive procedures. The strategic importance of this partnership lies in its potential to accelerate product development timelines and improve patient outcomes, thereby reinforcing Medtronic's competitive edge in the market. In September BASF SE (Germany) launched a new line of bioresorbable polymers specifically designed for orthopedic applications. This product introduction is significant as it addresses the increasing demand for innovative solutions in orthopedic surgery, where the need for temporary implants is rising. By expanding its product portfolio, BASF SE strengthens its market position and demonstrates its commitment to meeting evolving customer needs. In August Poly-Med Inc (US) secured a $5 million investment to enhance its R&D capabilities focused on bioresorbable sutures. This funding is crucial for advancing their technology and expanding their product offerings, which could lead to increased market penetration. The investment reflects a broader trend in the industry towards prioritizing R&D to foster innovation and maintain competitive differentiation. As of November current competitive trends indicate a strong emphasis on digitalization, sustainability, and the integration of AI technologies within the bioresorbable polymers market. Strategic alliances are increasingly shaping the landscape, enabling companies to pool resources and expertise to drive innovation. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on technological advancements, supply chain reliability, and sustainable practices, underscoring the importance of innovation in maintaining market leadership. ## Recent News & Developments The US Bioresorbable Polymers Market has seen notable developments recently. For instance, in January 2023, Medtronic announced advancements in its research initiatives focusing on bioresorbable materials aimed at enhancing patient recovery times. Various companies, including BASF and Evonik Industries, are increasing their investments in Research and Development to support the growing demand for biocompatible and sustainable materials in medical applications. Furthermore, PolyMedicure has expanded its product offerings, targeting the cardiovascular sector, capitalizing on the shift towards minimally invasive procedures.In terms of mergers and acquisitions, March 2023 marked a significant acquisition by Boehringer Ingelheim, which purchased a smaller biotech firm to strengthen its portfolio in regenerative medicine, including bioresorbable technologies. The US Bioresorbable Polymers Market is projected to grow, driven by advancements and increasing applications in medical devices, particularly in orthopedics and cardiology. Moreover, the recent emphasis on sustainability and eco-friendliness is influencing the development of bioresorbable materials across the industry. Noteworthy events in the last two to three years include the launch of innovative products by Sientra in June 2021 that further propelled the market's expansion. ## Report Scope | MARKET SIZE 2024 | 267.04 (USD Million) | | --- | --- | | MARKET SIZE 2025 | 301.22 (USD Million) | | MARKET SIZE 2035 | 1004.56 (USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 12.8% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | BASF SE (DE), Corbion NV (NL), Evonik Industries AG (DE), Medtronic PLC (IE), Boehringer Ingelheim GmbH (DE), Poly-Med Inc (US), Fujifilm Corporation (JP), Sientra Inc (US), Galatea Surgical Inc (US) | | Segments Covered | Type, Application | | Key Market Opportunities | Growing demand for sustainable medical devices drives innovation in the bioresorbable polymers market. | | Key Market Dynamics | Rising demand for sustainable medical solutions drives innovation in bioresorbable polymers within the US market. | | Countries Covered | US | ## Frequently Asked Questions **Q: What is the current valuation of the US bioresorbable polymers market?** A: The US bioresorbable polymers market was valued at 267.04 USD Million in 2024. **Q: What is the projected market size for the US bioresorbable polymers market by 2035?** A: The market is projected to reach 1004.56 USD Million by 2035. **Q: What is the expected CAGR for the US bioresorbable polymers market during the forecast period 2025 - 2035?** A: The expected CAGR for the market during this period is 12.8%. **Q: Which application segment holds the highest valuation in the US bioresorbable polymers market?** A: The Medical Devices segment holds the highest valuation, with figures reaching 320.0 USD Million. **Q: What are the key materials used in the US bioresorbable polymers market?** A: Key materials include Polylactic Acid, Polyglycolic Acid, Polycaprolactone, and Polyhydroxyalkanoates. **Q: Which end-use segment is projected to grow significantly in the US bioresorbable polymers market?** A: The Orthopedics end-use segment is projected to grow significantly, with a valuation of 320.0 USD Million. **Q: Who are the leading players in the US bioresorbable polymers market?** A: Key players include Baxter International Inc, Medtronic plc, and Stryker Corporation. **Q: What is the valuation of the Drug Delivery Systems segment in the US bioresorbable polymers market?** A: The Drug Delivery Systems segment was valued at 280.0 USD Million. **Q: How does the valuation of Polyhydroxyalkanoates compare to other materials in the market?** A: Polyhydroxyalkanoates has a valuation of 324.56 USD Million, making it one of the leading materials. **Q: What trends are expected to shape the US bioresorbable polymers market in the coming years?** A: Trends suggest a growing focus on innovative applications in medical devices and drug delivery systems. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-bioresorbable-polymers-market-13478*